Research Development Fund - Awarded Projects

The Research Development Fund was launched in February 2021 to fund projects that contribute to the development of clinical research, in turn leading to further research activity. 

The BHF CRC are pleased to announce that 12 applications have been successful to date, covering a variety of clinical cardiovascular specialities and themes.

Funded projects

  • A Cochrane Network Meta-Analysis of available evidence for oral antithrombotic agents in adults undergoing first-time CABG to assess their clinical effectiveness in reducing all-cause mortality after CABG surgery
  • A systematic review and data analysis to strengthen a grant application for a multi-centre randomised control trial to determine the safety and cost-utility of out-patient management services for acute heart failure compared to conventional in-patient management
  • Preparatory work to apply for funding for a cardio-oncology, multi-centre study of fluoropyrimidine cardiotoxicity to understand baseline cardiovascular risk and relationship with incident events and the role of pharmacological cardioprotection
  • Retrospective data analysis to determine whether the timing of echocardiography following admission with heart failure affects the risk of re-admission with heart failure and death
  • A comparative study of the accuracy and reproducibility for absolute blood flow and resistance measurements in coronary heart disease
  • Retrospective data analysis to identify which rhythm control option leads to better clinical outcomes (stroke, heart failure, and all-cause mortality) in the AF population in the UK and which intervention(s) is(are) more cost-effective for the whole population and specific patient groups.
  • Preparatory work for a grant application to the National Institute for Health Research/British Heart Foundation that will investigate the benefits of cardiac rehabilitation in people with non-obstructive coronary artery disease.
  • Pilot implementation of an AI algorithm in routinely-collected UK primary care electronic health records (EHRs). This algorithm can reduce the number of screenings needed for new atrial fibrillation cases in people ≥75 years of age to 11 whilst the national AF screening programme may prevent 10% of strokes and save the NHS £200 million per year.
  • Preparatory work including some initial data collection and feedback on trial design ahead of a funding application for a registry-based Randomised Controlled Trial (R-RCT) of furosemide versus bumetanide for the treatment of patients recently hospitalised with decompensated heart failure (FAB-HF).
  • Development of pragmatic methodology and intervention components ahead of a proposed multi-centre randomised controlled trial that compares patient centred ambulatory care supported by remote monitoring to usual outpatient clinic care for those with ACHD, by repurposing existing resources.
  • A Cochrane Network Meta-Analysis of transcatheter versus surgical treatments of secondary MR (sMR). The project will compare evidence from randomised controlled trials to better identify sMR patient subgroups who would benefit most from the respective interventions.
  • The project aims at establishing a database of cardiovascular patients using HES and linked mortality data. This database will be used to model trials in silico which in turn be used to inform funding applications for clinical trials that address priority research questions in cardiac surgery.